CN101199761B - Drug for treating arteriosclerosis - Google Patents
Drug for treating arteriosclerosis Download PDFInfo
- Publication number
- CN101199761B CN101199761B CN2007101148519A CN200710114851A CN101199761B CN 101199761 B CN101199761 B CN 101199761B CN 2007101148519 A CN2007101148519 A CN 2007101148519A CN 200710114851 A CN200710114851 A CN 200710114851A CN 101199761 B CN101199761 B CN 101199761B
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- rhizoma
- preparata
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating arteriosclerosis. The drug of the invention is prepared by Radix Ophiopogonis, roasted Carapax et Plastrum Testudinis, prepared Radix Polygoni Multiflori, Fructus Ligustri Lucidi, Radix Salviae Miltiorrhizae, Radix Codonopsis, fried Rhizoma Atractylodis Macrocephalae, Poria, roasted Radix Glycyrrhizae, Fructus Schisandrae, Ramulus Cinnamomi, Pollen Typhae, vinegarish Faeces Trogopterori, Flos Carthami, Fructus Trichosanthis, Bulbus Allii Macrostemi, prepared Rhizoma Pinelliae, Radix Cyathulae, Radix Platycodi and Rhizoma Gastrodiae in a certain weight proportion. The invention has the efficacies of reinforcing qi and warming yang,dissipating phlegm and removing blood stasis and has special effects on arteriosclerosis in heart, brain, kidney and limbs.
Description
(1) technical field
The present invention relates to the arteriosclerotic medicine of a kind of treatment, particularly a kind of is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
(2) background technology
Arteriosclerosis is common ailment of middle-aged and old, and age of onset has rejuvenation trend.Doctor trained in Western medicine is not bright to the arteriosclerotic definite cause of disease, and theory of Chinese medical science thinks that arteriosclerosis is that the cold-phlegm arthralgia due to blood stasis hinders in passages through which vital energy circulates, so that sering is unfavorable owing to visceral dysfunction, and QI-blood circulation is obstructed, and internal organs muscle arteries and veins loses supports.Clinical manifestation is heavy for headache, dizzy, tinnitus, intelligence hypomnesis, brothers, numbness of the skin, cardiopalmus sensation of oppression over the chest with shortness of breath etc.The arteriosclerotic Chinese Traditional Medicines of treatment are few at present, and effect is not quite desirable; Though the Western medicine style is many, all cause the side effect of gastrointestinal tract and digestive system mostly.
(3) summary of the invention
The objective of the invention is to overcome deficiency of the prior art, provide a kind of and have no side effect, instant effect has QI invigorating warming YANG, dissipating phlegm and removing blood stasis, cures mainly heart and brain kidney and the hardened medicine of artery of extremity.
The present invention realizes by following measure:
The present invention treat arteriosclerotic medicine by following raw materials by weight portion than making:
Radix Ophiopogonis 20~30, Carapax et Plastrum Testudinis 20~30, Radix Polygoni Multiflori Preparata 20~30, Fructus Ligustri Lucidi 10~20,
Cortex Moutan 3~10, Radix Codonopsis 10~20, the Rhizoma Atractylodis Macrocephalae 10~20, Poria 10~20,
Radix Glycyrrhizae Preparata 3~10, Fructus Schisandrae Chinensis 3~10, Ramulus Cinnamomi 3~10, Pollen Typhae 3~10,
Stir-baked FAECES TROGOPTERORI with vinegar 3~10, Flos Carthami 3~10, Fructus Trichosanthis 10~20, Bulbus Allii Macrostemonis 3~10,
Rhizoma Pinelliae Preparata 3~10, Radix Cyathulae 10~20, Radix Platycodonis 3~10, Rhizoma Gastrodiae 3~10.
The present invention treats arteriosclerotic medicine, and described raw material optimum ratio is:
Radix Ophiopogonis 30, Carapax et Plastrum Testudinis 30, Radix Polygoni Multiflori Preparata 30, Fructus Ligustri Lucidi 15,
Cortex Moutan 10, Radix Codonopsis 15, the Rhizoma Atractylodis Macrocephalae 15, Poria 15,
Radix Glycyrrhizae Preparata 6, Fructus Schisandrae Chinensis 6, Ramulus Cinnamomi 9, Pollen Typhae 10,
Stir-baked FAECES TROGOPTERORI with vinegar 10, Flos Carthami 10, Fructus Trichosanthis 15, Bulbus Allii Macrostemonis 10,
Rhizoma Pinelliae Preparata 10, Radix Cyathulae 15, Radix Platycodonis 10, Rhizoma Gastrodiae 10.
We are foundation with the theory of Chinese medical science, and are dialectical in conjunction with differential diagnosis of diseases, treating both the principal and secondary aspects of a disease.Arteries and veins belongs to extraordinary Fu-organ, ancestor's " interior warp " " the heart controlling the blood vessels of the whole body ", and normally whether " ying-qi is held back in heap soil or fertilizer over and around the roots, and order does not have institute and keeps away, and is the meaning arteries and veins " sering function depends primarily on the warm of heart-yang, and moistening of painstaking effort is foster, and be also closely related with liver spleen renal function coordinated balance.Radix Codonopsis of the present invention, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, Fructus Schisandrae Chinensis, Ramulus Cinnamomi, help heart-yang at reinforcing the heart gas, the multiple arteries and veins of hemopoietic.
Described Fructus Trichosanthis, Bulbus Allii Macrostemonis, the Rhizoma Pinelliae activate yang let out turbid, the eliminating phlegm eliminating stagnation.
Described Pollen Typhae, stir-baked FAECES TROGOPTERORI with vinegar, Flos Carthami, Cortex Moutan promoting blood circulation to disperse blood clots and relieves pain.
Described Radix Ophiopogonis, Carapax et Plastrum Testudinis, Radix Polygoni Multiflori Preparata, Fructus Ligustri Lucidi, Rhizoma Gastrodiae liver and kidney tonifying, nourishing YIN for suppressing the hyperactive YANG.
Described Radix Platycodonis, Radix Cyathulae open lung qi dispersing gas, promoting blood circulation.
The present invention treats arteriosclerotic process for preparing medicine: take by weighing raw material by above ratio of weight and number, carry out dry sterilization after removing impurity and cleaning and disinfect, be ground into fine powder, merging stirs, pack, 3 gram/bags.
Usage and consumption: oral, obey 3 grams, one day three times at every turn.
The invention has the beneficial effects as follows: the QI invigorating warming YANG, dissipating phlegm and removing blood stasis,, numb limbs and tense tendons uncomfortable in chest to dizziness and tinnitus, cardiopalmus due to heart and brain kidney and the artery of extremity sclerosis has specially good effect, and the energy blood fat-reducing blood pressure-decreasing, alleviates hypercoagulability, promotes side Zhi Xunhuan to form.
(4) specific embodiment
Embodiment 1:
Take by weighing 30g Radix Ophiopogonis, Carapax et Plastrum Testudinis 30g, Radix Polygoni Multiflori Preparata 30g, Fructus Ligustri Lucidi 15g, Cortex Moutan 10g, Radix Codonopsis 15g, Rhizoma Atractylodis Macrocephalae 15g, Poria 15g, Radix Glycyrrhizae Preparata 6g, Fructus Schisandrae Chinensis 6g, Ramulus Cinnamomi 9g, Pollen Typhae 10g, stir-baked FAECES TROGOPTERORI with vinegar 10g, Flos Carthami 10g, Fructus Trichosanthis 15g, Bulbus Allii Macrostemonis 10g, Rhizoma Pinelliae Preparata 10g, Radix Cyathulae 15g, Radix Platycodonis 10g, Rhizoma Gastrodiae 10g.Take by weighing raw material by above parts by weight, carry out dry sterilization after removing impurity and cleaning and disinfect, be ground into fine powder, merging stirs, pack, 3 gram/bags.
Embodiment 2:
Take by weighing 25g Radix Ophiopogonis, Carapax et Plastrum Testudinis 22g, Radix Polygoni Multiflori Preparata 25g, Fructus Ligustri Lucidi 20g, Cortex Moutan 3g, Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 18g, Poria 10g, Radix Glycyrrhizae Preparata 10g, Fructus Schisandrae Chinensis 3g, Ramulus Cinnamomi 9g, Pollen Typhae 5g, stir-baked FAECES TROGOPTERORI with vinegar 5g, Flos Carthami 6g, Fructus Trichosanthis 20g, Bulbus Allii Macrostemonis 6g, Rhizoma Pinelliae Preparata 6g, Radix Cyathulae 10g, Radix Platycodonis 6g, Rhizoma Gastrodiae 3g.Take by weighing raw material by above parts by weight, carry out dry sterilization after removing impurity and cleaning and disinfect, be ground into fine powder, merging stirs, pack, 3 gram/bags.
Embodiment 3:
Take by weighing 20g Radix Ophiopogonis, Carapax et Plastrum Testudinis 26g, Radix Polygoni Multiflori Preparata 20g, Fructus Ligustri Lucidi 10g, Cortex Moutan 6g, Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae 10g, Poria 20g, Radix Glycyrrhizae Preparata 3g, Fructus Schisandrae Chinensis 10g, Ramulus Cinnamomi 3g, Pollen Typhae 3g, stir-baked FAECES TROGOPTERORI with vinegar 3g, Flos Carthami 3g, Fructus Trichosanthis 10g, Bulbus Allii Macrostemonis 3g, Rhizoma Pinelliae Preparata 3g, Radix Cyathulae 20g, Radix Platycodonis 3g, Rhizoma Gastrodiae 8g.Take by weighing raw material by above parts by weight, carry out dry sterilization after removing impurity and cleaning and disinfect, be ground into fine powder, merging stirs, and is ground into fine powder, pack, 3 gram/bags.
For the proof effect of drugs of the present invention, select 826 patients to carry out patient's clinical experiment, with 30 days be a course of treatment, carry out electrocardio, X line, blood pressure blood fat, examination of ocular fundus after two courses of treatment.
Curative effect judging standard:
1, cures: various transference cures.
2, take a turn for the better: every index is recovered normal or is taken a turn for the better.
3, invalid: every index increases the weight of or does not have an improvement.
Clinical statistics is analyzed as follows shown in the table:
In 826 patients, cure 484 examples, account for 58.6%, 248 examples that take a turn for the better, total effective rate reaches 88.6%.
Claims (3)
- One kind the treatment arteriosclerotic medicine, it is characterized in that: by following raw materials by weight portion than making:Radix Ophiopogonis 20~30, Carapax et Plastrum Testudinis 20~30, Radix Polygoni Multiflori Preparata 20~30, Fructus Ligustri Lucidi 10~20,Cortex Moutan 3~10, Radix Codonopsis 10~20, the Rhizoma Atractylodis Macrocephalae 10~20, Poria 10~20,Radix Glycyrrhizae Preparata 3~10, Fructus Schisandrae Chinensis 3~10, Ramulus Cinnamomi 3~10, Pollen Typhae 3~10,Stir-baked FAECES TROGOPTERORI with vinegar 3~10, Flos Carthami 3~10, Fructus Trichosanthis 10~20, Bulbus Allii Macrostemonis 3~10,Rhizoma Pinelliae Preparata 3~10, Radix Cyathulae 10~20, Radix Platycodonis 3~10, Rhizoma Gastrodiae 3~10.
- 2. the arteriosclerotic medicine of treatment according to claim 1 is characterized in that:Described raw material optimum ratio is:Radix Ophiopogonis 30, Carapax et Plastrum Testudinis 30, Radix Polygoni Multiflori Preparata 30, Fructus Ligustri Lucidi 15,Cortex Moutan 10, Radix Codonopsis 15, the Rhizoma Atractylodis Macrocephalae 15, Poria 15,Radix Glycyrrhizae Preparata 6, Fructus Schisandrae Chinensis 6, Ramulus Cinnamomi 9, Pollen Typhae 10,Stir-baked FAECES TROGOPTERORI with vinegar 10, Flos Carthami 10, Fructus Trichosanthis 15, Bulbus Allii Macrostemonis 10,Rhizoma Pinelliae Preparata 10, Radix Cyathulae 15, Radix Platycodonis 10, Rhizoma Gastrodiae 10.
- 3. the arteriosclerotic medicine of treatment according to claim 1 is characterized in that: the dosage form of described medicine is powder, capsule or tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101148519A CN101199761B (en) | 2007-12-04 | 2007-12-04 | Drug for treating arteriosclerosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101148519A CN101199761B (en) | 2007-12-04 | 2007-12-04 | Drug for treating arteriosclerosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101199761A CN101199761A (en) | 2008-06-18 |
CN101199761B true CN101199761B (en) | 2010-06-09 |
Family
ID=39515244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101148519A Expired - Fee Related CN101199761B (en) | 2007-12-04 | 2007-12-04 | Drug for treating arteriosclerosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101199761B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071115B (en) * | 2013-01-06 | 2014-06-25 | 陈明荣 | Traditional Chinese medicine preparation for treating coronary sclerosis |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104383163A (en) * | 2014-12-02 | 2015-03-04 | 宋婷婷 | Pharmaceutical composition for treating atherosclerosis of aorta |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
CN1371728A (en) * | 2002-01-15 | 2002-10-02 | 吕劲松 | Powder medicine for promoting blood circulation and removing blood stasis |
-
2007
- 2007-12-04 CN CN2007101148519A patent/CN101199761B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
CN1371728A (en) * | 2002-01-15 | 2002-10-02 | 吕劲松 | Powder medicine for promoting blood circulation and removing blood stasis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071115B (en) * | 2013-01-06 | 2014-06-25 | 陈明荣 | Traditional Chinese medicine preparation for treating coronary sclerosis |
Also Published As
Publication number | Publication date |
---|---|
CN101199761A (en) | 2008-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101461921B (en) | Medicinal composition for treating gynecopathy | |
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN103463568B (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN101732683A (en) | Chinese medicinal preparation for treating facial chloasma and preparation method thereof | |
CN101637579A (en) | Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof | |
CN105250723A (en) | Medicine for treating diabetes | |
CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN103142865A (en) | Traditional Chinese medicine for treating hypertension | |
CN103330835A (en) | Traditional Chinese medicine composition for treating climacteric syndromes | |
CN101199761B (en) | Drug for treating arteriosclerosis | |
CN102580030B (en) | External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method | |
CN103990009A (en) | Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness | |
CN102940716A (en) | Traditional Chinese medicine for treatment of uterine prolapse | |
CN106377621A (en) | Preparation method of traditional Chinese medicine composition for treating premature graying of beards and hair | |
CN101703660B (en) | Anti-aging medicament | |
CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
CN101564505A (en) | Chinese medicament for treating pulmonary heart disease | |
CN103212041A (en) | Chinese medicinal composition treating coronary heart disease | |
CN102166303B (en) | Chinese medicinal composition for treating chronic atrophic gastritis | |
CN101537114A (en) | Chinese medicine for treating arrhythmia | |
CN105688068A (en) | Chinese herbal preparation for treating arrhythmia and preparing method of Chinese herbal preparation | |
CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN105250864A (en) | Traditional Chinese medicine for treating visceral dysfunction | |
CN104383270A (en) | Medicine for treating coronary heart diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20101204 |